Skip to main content

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SPLK, TCDA and DECN

NEW YORK, NY / ACCESSWIRE / February 1, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Splunk Inc. (NASDAQ:SPLK)
Class Period: August 26, 2020 - December 2, 2020
Lead Plaintiff Deadline: February 2, 2021

The complaint alleges that during the class period Splunk Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Splunk was not closing deals with its largest customers in the third fiscal quarter of 2021; (2) Splunk was not hitting the financial targets it had previously announced; and (3) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in SPLK: http://www.kleinstocklaw.com/pslra-1/splunk-inc-loss-submission-form?id=12604&from=1

Tricida, Inc. (NASDAQ:TCDA)
Class Period: September 4, 2019 - October 28, 2020
Lead Plaintiff Deadline: March 8, 2021

The TCDA lawsuit alleges that Tricida, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Tricida's NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in TCDA: http://www.kleinstocklaw.com/pslra-1/tricida-inc-loss-submission-form?id=12604&from=1

Decision Diagnostics Corp. (OTCMKT:DECN)
Class Period: March 3, 2020 - December 17, 2020
Lead Plaintiff Deadline: March 16, 2021

The DECN lawsuit alleges Decision Diagnostics Corp. made materially false and/or misleading statements and/or failed to disclose during the class period that: (i) Decision Diagnostics had not developed any viable COVID-19 test, much less a test that could detect COVID-19 in less than one minute; (ii) the Company could not meet the FDA's EUA testing requirements for its purported COVID-19 test; (iii) accordingly, Defendants had misrepresented the timeline within which it could realistically bring its COVID-19 test to market; (iv) all the foregoing subjected Defendants to an increased risk of regulatory oversight and enforcement; and (v) as a result, Defendants' public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in DECN: http://www.kleinstocklaw.com/pslra-1/decision-diagnostics-corp-loss-submission-form?id=12604&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/627247/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-SPLK-TCDA-and-DECN

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.